All the latest worldwide HIV and AIDS news, including treatment, prevention, and hepatitis and TB co-infections. News from our own team of writers plus articles we have selected from other sources.

aidsmap hiv & aids news


← First12345...798Next →

hiv & aids news selected from other sources

  • Harm reduction
    The Success of Italy’s Community-Based Approach to Naloxone
    Talking Drugs | 8 hours ago

    The provision of naloxone by community-based harm reduction services, as takes place in Italy, is highly important for reducing the harms of opioid drugs, a report suggests.

  • How HIV causes disease
    Pretreatment HIV, immune activation levels determine their persistence during treatment
    Eurekalert Inf Dis | 9 hours ago

    A study led by a Massachusetts General Hospital investigator finds that pretreatment levels of HIV and immune activation appear to determine the extent to which viral levels and inflammation persist during antiretroviral treatment.

  • Hepatitis C symptoms and diagnosis
    New Canadian guideline: No screening for hepatitis C in adults not at increased risk
    Eurekalert Inf Dis | 9 hours ago

    The Canadian Task Force on Preventive Health Care recommends against screening for chronic hepatitis C virus in adults at low risk in a guideline published in Canadian Medical Association Journal.

  • UK health services
    Complexity of health system is 'holding back progress' in HIV care
    The King's Fund | 9 hours ago

    While HIV care in England is among the best in the world, the Health and Social Care Act 2012 has created a complex and fragmented system for HIV care. Responsibility for delivering services is spread between NHS England, local NHS organisations and councils, which has made it harder for areas to make co-ordinated changes across HIV services.

  • Harm reduction
    Canada is paving the way to import prescription heroin in bulk
    Vice | 24 April 2017

    Canada’s health minister has said prescribing heroin could help reduce overdose deaths, so Ottawa is allowing large imports of the prescription drug.

  • Hepatitis B
    EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
    EASL | 24 April 2017

    Hepatitis B virus (HBV) infection remains a global public health problem with changing epidemiology due to several factors including vaccination policies and migration. This Clinical Practice Guideline presents updated recommendations for the optimal management of HBV infection.

  • Global health initiatives
    Three countries get first malaria vaccine
    BBC | 24 April 2017

    The world's first vaccine against malaria will be introduced in three countries - Ghana, Kenya and Malawi - starting in 2018. The four-shot vaccine should prevent four in 10 cases of the disease.

  • Harm reduction
    Healing Austin, Indiana: How town raced to stop America's worst rural HIV plague (three-part series)
    Kentucky Courier-Journal | 24 April 2017

    Critics say Mike Pence was slow to react as a festering blight, then HIV gripped Austin, Indiana. This tiny city off Interstate 65 is the epicenter of a medical disaster. Dr. Tom Frieden, former director of the U.S. Centers for Disease Control and Prevention, confirms Austin contains the largest drug-fueled HIV outbreak to hit rural America in recent history, and "the largest concentrated outbreak ever documented in the United States."

  • PrEP
    BHIVA response to The Irish Times article 'Anti-HIV drug removes personal responsibility'
    BHIVA | 24 April 2017

    This piece has generated a considerable amount of concern in the HIV community already as its content is completely at odds with current recommendations by the World Health Organisation and NICE which recognise that HIV pre-exposure prophylaxis (PrEP) is an important component of HIV prevention. Numerous studies have shown that PrEP is a highly clinically and cost-effective safe intervention which reduces the risk of becoming infected with HIV by around 90%.

  • Hepatitis C
    New hepatitis data highlight need for urgent global response
    World Health Organization | 21 April 2017

    New WHO data reveal that an estimated 325 million people worldwide are living with chronic hepatitis B virus (HBV) or hepatitis C virus (HCV) infection. The WHO Global hepatitis report, 2017 indicates that the large majority of these people lack access to life-saving testing and treatment. As a result, millions of people are at risk of a slow progression to chronic liver disease, cancer, and death.

← First12345...1304Next →

Conference news

News from the Conference on Retroviruses and Opportunistic Infections (CROI 2017).

HIV update

Sign up for HIV update, our fortnightly news bulletin for people living with HIV in the UK.

Achieving the 90-90-90 target

With advances in HIV testing, treatment and care, some countries are making great progress towards the UNAIDS 90-90-90 target.

aidsmap news apps

Download the free aidsmap news iPhone and android apps.

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.